Dyne Therapeutics
Company Details
Status: Public
Employees: 101-250
Location:
Waltham, Massachusetts, United States of America
Type:
sample
Technology:
sample
sample
sample
sample
About: Dyne Therapeutics is a clinical-stage muscle disease company focused on advancing innovative life-transforming therapeutics for people living with genetically driven diseases. With its proprietary FORCE™ platform, Dyne is developing modern oligonucleotide therapeutics that are designed to overcome limitations in delivery to muscle tissue. Dyne has a broad pipeline for serious muscle diseases, including clinical programs for myotonic dystrophy type 1 (DM1) and Duchenne muscular dystrophy (DMD) and a preclinical program for facioscapulohumeral muscular dystrophy (FSHD). For more information, please visit https://www.dyne-tx.com.
To view our community guidelines, click here: https://bit.ly/3BYPnpK
Unlock access to company contacts, hot leads, and drug pipelines.
Log in or create a free account now!
Dyne Therapeutics | Active clinical trials on ClinicalTrials.gov
Active Clinical Trials Count | 0
No Active Trials Found On ClinicalTrials.gov.